A fascinating glimpse inside the life-and-death business ofbiotechnology. "A tour-de-force for anyone who is interested in the biotechindustry. I applaud the enormous achievement of CynthiaRobbins-Roth." -Frederick Frank, Senior Managing Director Vice Chair, Lehman Brothers "From Alchemy to IPO tells the dramatic story of thisrevolutionary industry as only an insider can." -George Rathmann,President and CEO, ICOS Corporation, Chairman Emeritus, Amgen Written by a well-known industry insider, From Alchemy to IPOaddresses the coming-of-age of biotech products and companies andtraces the history of biotechnology from its early inception in theseventies to today's heyday of new solutions and breakthroughtreatments. It describes the amazing entrepreneurial trail ofproduct development, novel business models, and critical trialsthat eventually pave the way to market. This is the first book toaccurately record the inner workings of anindustry-biotechnology-that's on the verge of living up to
